Young researchers in Reutlingen: A group of students from Albstadt-Sigmaringen University spent the last three days at the NMI and gained an insight into the work of the researchers. Young researchers

Researchers led by Dr. Michael Pawlak from NMI TT GmbH and Prof. Dr. Hans Neubauer from the Women's Clinic at the University of Düsseldorf have developed a new method that enables a more precise analy

Tiny holes, big opportunities: a nanodiag BW project meeting took place at the NMI today. Presentations and discussions focused on production and applications. Tiny holes, great opportunities: Today (

The submitted project is about models for the development of new therapeutic options for cancer treatment. Every two years, the association Ärzte gegen Tierversuche e.V. (Doctors Against Animal Experi

$60M program focusing on Dynamic Resilience from Wellcome Leap and Temasek Trust funds international research group led by Tübingen professor Dynamic resilience, the ability of humans to withstand une

More than seven million people in Germany suffer from diabetes. Drug research is still difficult. Scientists led by Peter Loskill from the NMI and the University of Tübingen have developed a technique

Does our therapeutic approach work against cancer? A planned NMI spin-off has developed a technology that shall answer this question more quickly - and thus save valuable time for patients and money f

Heal-X Bioink: The new chapter in 3D bioprinting begins! Today saw the much-anticipated kick-off of the BMBF-funded Heal-X Bioink project, which focuses on the development of a self-healing, bio-inspi

Dr. Teresa Wagner receives the PI Innovation Award for groundbreaking cancer research that leads to a spin-out activity at the NMI The newly introduced PI Innovation Award for outstanding research at

The EUROoCS Conference 2024 in Milan is over and the µOrganoLab team is delighted with its great success. The EUROoCS Academy organized by the 3R-Center Tübingen and the EUROoCS working group "Teachin